CN102716373A - Prescription for treating oncosis and preparation method thereof - Google Patents
Prescription for treating oncosis and preparation method thereof Download PDFInfo
- Publication number
- CN102716373A CN102716373A CN201110262467XA CN201110262467A CN102716373A CN 102716373 A CN102716373 A CN 102716373A CN 201110262467X A CN201110262467X A CN 201110262467XA CN 201110262467 A CN201110262467 A CN 201110262467A CN 102716373 A CN102716373 A CN 102716373A
- Authority
- CN
- China
- Prior art keywords
- medicine
- wine
- oncosis
- proportion
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine for treating tumor, comprising Oldenlandia diffusa, barbed skullcap herb, coix seeds, Boletus edulis, Cordyceps sinensis, Astragalus mongholicus, safflower, and auxiliary wine. The medicine is prepared by crushing the ingredients into fine powder and mixing uniformly with wine in proportion to prepare pills, or immersing the ingredients in wine in proportion to prepare medicinal liquor. The medicine is a pure natural medicine with no additive, no toxicity and no side effect, has the advantages of quick absorption, high curative effect, low price, and easy portability, is a effective prescription for treating tumor. The medicine has the effects of treating benign tumors, inhibiting the propagation of malignant tumors, preventing the metastasis and recurrence of cancer cells, and enhancing the body function of resisting cancer and swelling, and is suitable for treating various tumors.
Description
Affiliated technical field:
It belongs to the Chinese medicine scope and the method for preparing of tumor Chinese medicine.
It relates to carcinoid Chinese medicine.
Background technology:
1. known traditional Chinese medicine tumor is with a long history, and means emerge in an endless stream.Medicine is thousands of, and in the prolongation of the life cycle of improving tumor patient, advantage such as improve the quality of living is confirmed by numerous clinical research.Can only cooperate western medical treatment but the Chinese traditional treatment tumor also rests on so far, in other words, the Chinese medicine tumor is in the status of auxiliary treatment, can not bear a line important task of oncotherapy.It recovers the effect of healthy energy with the Chinese medicine performance behind surgical operation; Behind radiotherapy, strengthen the effect of regulating immune function with Chinese medicine, behind the process chemotherapeutic treatment; Be used for the hemopoietic system of medicine activation inhibition etc.; In a word, Chinese medicine can not be cured tumor separately so far, is confined to set upright conditioning.And the fried of Chinese medicine will spend the plenty of time, takes and carry inconvenience.
2. though known doctor trained in Western medicine can be effected a radical cure tumor, has fatal defective.As: surgical operation, the possibility that not only has recurrence, focus to shift, and also small remaining focus is difficult to eradicate.Draw " the east wind P259 of the treating malignant tumor handbook Yin Dynasty (Liaoning science and technology publishing house).Though and radiotherapy have nowhere less than function; But in killing tumor cell; Toxic and side effects also in various degree damage normal cell (chemical examination confirm); Medical treatment, though by the cellular level progress to molecular level, most chemotherapeutic can suppress immune system and hemopoietic system.The Biotherapeutics of releasing at present, expensive not only, but also have many an open questions still.Draw " tumor rationale " Li Qing P83 (publishing house of The Fourth Military Medical University).In a word, the big order of Western medicine side effect can not thoroughly effect a radical cure.
1. the purpose of inventing:
Oncosis is the disease of cytometaplasia, and promptly relevant with cell proliferation gene is unlocked, thereby and the gene relevant with cell differentiation is closed the constraint that tumor cell shown as do not receive body and the infinite multiplication state.It is exactly the object of the invention that medication inducing tumor cell differentiation inhibition tumor cell proliferation causes the death of tumor cell.
2. the technical problem that will solve:
Problems such as it is low to solve traditional Chinese medical science curative effect, and the doctor trained in Western medicine side effect is big.
The technical scheme that the present invention adopts: the congestion that promotes tumor cell with Radix Astragali QI invigorating is popular; Add adjuvant wine with Cordyceps, engulf tumor cell fast, and Cordyceps is regulated the effect of enhance immunity system in addition; Promoting leucocytes and hematoblastic quantity (result of laboratory test confirmation); Use Herba Hedyotidis Diffusae, Suillus albidipes (Peck) Sing., Semen Coicis killing tumor cell (result of laboratory test confirmation) activate with the blood of Flos Carthami with the alluvial in the tumor cell; Therefore it is to cure tumor, the i.e. capable theory of the capable then blood of the gas of the traditional Chinese medical science through QI invigorating eliminating stagnation means.In a word, it be through the Chinese medicine immunoregulation effect strengthen the human body host defence mechanism to the characteristic of tumor cell obtain to it inhibition and kill and wound.Prevent the relapse and metastasis of tumor cell.Not only protected normal cell but also killed and wounded the tumor cell of variation, promptly set upright with eliminating evil (pressing down tumor) and carry out simultaneously.It is the medicament of being processed by subordinate's materials of weight proportions medical material:
Herba Hedyotidis Diffusae, 10～30 Suillus albidipes (Peck) Sing.s 10～15
Cordyceps 10～15 Radixs Astragali 9～13 Semen Coiciss 10～15
Herba Scutellariae Barbatae 10～15 Flos Carthamis 3～9 usefulness processed with wine become ball.
Cordyceps: 1, the source for the Clavicipitaceae winter worm colonize in Hepialidae insect larvae Stroma and larva cadaveric complex on one's body.2, chemical constituent: 1. crude protein accounts for 20-30%,
2. 3. ucleosides of Cordyceps polysaccharide 6-7% contains cordycepin, Cordycepin.4. adenosine class.Wherein Cordyceps polysaccharide has the function of immunomodulating human body, and antineoplastic action is arranged.And adenosine constituents such as cordycepin all have anti-inflammation, and antitumor is the main active substances of Cordyceps.3 its pharmacological actions: promote the human body functional rehabilitation; Antiasthmatic-antitussive, bring high blood pressure down, antithrombotic forms, cholesterol reducing and three oily slow down aging; Improve cellular immunization, antitumor etc. are also intended androgen and the synthetic and secretion of estrogen-like effects adjusting sexual function enhancing adrenal hormone.Synthetic and the secretion that wherein strengthens adrenal hormone obtain antitumor with the male estrogen of balance the inhibitory hormone dependent tumors.
The Radix Astragali: 1. originate: be leguminous plant, the dry root of Radix Astagali.2. chemical constituent: 1. saponins, 2. 3. polysaccharide of flavonoid.Wherein astragalus polysaccharides has that to strengthen cellular immunization active, suppresses tumor cell, and 3, pharmacological action: have and strengthen or regulate body's immunity; Leukocyte increasing and erythrocytic number increase content of hemoglobin, promote the body metabolism defying age; Resisting fatigue protects the liver blood sugar lowering, blood pressure lowering; Eliminate urine protein, antitumor still has estrogen-like effects.
Herba Hedyotidis Diffusae: 1 source: be herb 2. chemical constituents of Maguireothamnus speciosus Herba Hedyotidis Diffusae: 1. contain glycoside and 2. still contain the pier fruit acid, ursolic acid, to a coumaric acid, bean nest alcohol 3. polysaccharide has tangible enhancing human body immunity activity and antitumaous effect.3, pharmacological action: stimulate netted meat skin system hypertrophy, enhancing antibody forms.Make skein cell, leukocytic phagocytic activity strengthens and antimicrobial antiphlogistic under high concentration, all has inhibitory action to the sarcoma leukaemia cancer cell.
Suillus albidipes (Peck) Sing.: 1, source: be dried sporophore 2. chemical constituents of Polyporaceae fungus: 1. 2. triterpene acids of polysaccharide.3. nest alcohols, 4. various alkaloids.Wherein, the polysaccharide antitumor improves immunity, polypeptide, defying age.3. pharmacological action: (summary)
Herba Scutellariae Barbatae: 1. originate: be the dry herb of labiate Herba Scutellariae Barbatae.2. chemical constituent: 1. contain flavonoid and 2. still contain 3. 4. various alkaloid 3. pharmacological actions of triterpenes of polysaccharide: (summary)
Semen Coicis source: be the dry mature kernal of standing grain section plant.2. chemical constituent: 1. 3. 3. pharmacological actions such as acidic polysaccharose CA-1, CA-2 and glucosan of the 2. neutral glucosan 1-7 of Semen Coicis polysaccharide (coixan) ABC: (summary)
Flos Carthami: 1. originate: be the dried floral of feverfew Flos Carthami.2. pharmacological action: coronary blood flow increasing, blood vessel dilating, blood pressure lowering, anticoagulant, the blood fat reducing anti-hypoxia is regulated immunologic function.3. chemical constituent: (summary)
3. its beneficial effect:
The clinical use result of the present invention, through tracking statistics to each case, after 520 people's tumor patients that B ultrasonic is made a definite diagnosis use, cure rate 100%.The 51 routine patients that make a definite diagnosis at X-ray use the back cure rate more than 95%.15 routine leukemia skin carcinomas are taken the back cancerous cell and almost are inhibited.
4. its feature:
It has curative effect fast, carries taking convenience, and safety has no side effect, and adapts to various oncotherapys, and it will bring glad tidings to tumor patient, writes new page for the tumor Chinese medicine.
Claims (4)
1. Chinese medicine that is used to treat oncosis.It is characterized in that it is the medicament by following weight parts proportion raw material medical material system.(dosage is gram)
Herba Hedyotidis Diffusae, 10～30 Suillus albidipes (Peck) Sing.s 10～15
Cordyceps 10～15 Radixs Astragali 9～13 Semen Coiciss 10～15
Herba Scutellariae Barbatae 10～15 Flos Carthamis 3～9 usefulness processed with wine become ball.
2. as claimed in claim 1ly be used to treat oncosis Chinese medicine, it is characterized in that said medicament is a said dosage form on any pharmaceutics.
3. like the right 1 described method for preparing that is used to treat oncosis, it is characterized in that weighing in proportion medical material, be made as fine powder (being crushed to particle diameter 200～250 orders) reuse processed with wine respectively and become ball.
4. like the right 1 described method for preparing that is used to treat oncosis, it is characterized in that forming with the steeping in wine bubble with weighing medical material in proportion
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110262467XA CN102716373A (en) | 2011-09-06 | 2011-09-06 | Prescription for treating oncosis and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110262467XA CN102716373A (en) | 2011-09-06 | 2011-09-06 | Prescription for treating oncosis and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102716373A true CN102716373A (en) | 2012-10-10 |
Family
ID=46942327
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201110262467XA Pending CN102716373A (en) | 2011-09-06 | 2011-09-06 | Prescription for treating oncosis and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102716373A (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1208630A (en) * | 1997-08-14 | 1999-02-24 | 崔兴 | Traditional Chinese medicine series used for anticancer and method for preparing same |
| US20020164352A1 (en) * | 2000-02-28 | 2002-11-07 | Bruno Donatini | Novel pharmaceutical or dietetic mushroom-based compositions |
| JP2004224702A (en) * | 2003-01-20 | 2004-08-12 | Ichimaru Pharcos Co Ltd | External preparation for skin containing mushroom extract |
| US20050002962A1 (en) * | 2003-04-16 | 2005-01-06 | David Pasco | Immunostimulatory agents in botanicals |
| CN101095699A (en) * | 2006-07-02 | 2008-01-02 | 蔡勇 | Anticancer epiphyte composition and method of making the same |
| CN101837065A (en) * | 2010-05-13 | 2010-09-22 | 粤北人民医院 | Medicine with anti-hepatitis, anti-tumour and organism immunity improving functions and preparation method thereof |
-
2011
- 2011-09-06 CN CN201110262467XA patent/CN102716373A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1208630A (en) * | 1997-08-14 | 1999-02-24 | 崔兴 | Traditional Chinese medicine series used for anticancer and method for preparing same |
| US20020164352A1 (en) * | 2000-02-28 | 2002-11-07 | Bruno Donatini | Novel pharmaceutical or dietetic mushroom-based compositions |
| JP2004224702A (en) * | 2003-01-20 | 2004-08-12 | Ichimaru Pharcos Co Ltd | External preparation for skin containing mushroom extract |
| US20050002962A1 (en) * | 2003-04-16 | 2005-01-06 | David Pasco | Immunostimulatory agents in botanicals |
| CN101095699A (en) * | 2006-07-02 | 2008-01-02 | 蔡勇 | Anticancer epiphyte composition and method of making the same |
| CN101837065A (en) * | 2010-05-13 | 2010-09-22 | 粤北人民医院 | Medicine with anti-hepatitis, anti-tumour and organism immunity improving functions and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 赵建成等: "《肿瘤方剂大辞典》", 30 April 2009, 中医古籍出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108524814A (en) | A kind of Chinese medicine composition and preparation method thereof for reducing blood glucose | |
| CN103041173A (en) | Traditional Chinese medicine external preparation for curing dermatitis and eczema and preparing method thereof | |
| CN103386022B (en) | Chinese medicine composition for treating tuberculous pleurisy | |
| CN103156122A (en) | Health-care Astragalus mongholicus porridge and preparation method thereof | |
| CN103239624B (en) | Chinese medicine for treating oligospermia and asthenozoospermia owning to insufficiency of both spleen and kidney | |
| CN102579514A (en) | Method for processing alangium platanifolium | |
| CN102872385B (en) | Compound Chinese medicinal composition for treating advanced gastric cancer and preparation method and application thereof | |
| CN102488795A (en) | Medicine for treating radiation dermatitis after head neck radiotheraphy | |
| CN105213584A (en) | A kind of Chinese medicine composition for the treatment of eczema and preparation method thereof | |
| CN108403932A (en) | A kind of Chinese medicine compound prescription external preparation and its preparation method and application for treating steroid dependent dermatitis | |
| CN103933386B (en) | Compound hemophiliac capsule used for treating hemophilia and preparation method thereof | |
| CN114177261A (en) | Chinese herbal medicine formula for preventing and treating chronic diseases and resisting cancer and protecting health | |
| CN104095912B (en) | Treat the preparation method of the Chinese patent drug of rheumatism bone disease | |
| CN103202976B (en) | Traditional Chinese medicine extract for treating myasthenia gravis and preparation method thereof | |
| CN102716373A (en) | Prescription for treating oncosis and preparation method thereof | |
| CN102423384B (en) | Traditional Chinese drug preparation for treating lung cancer, and preparation method thereof | |
| CN102008697B (en) | Medicinal liquor for curing nephropathy and preparation method thereof | |
| CN100411663C (en) | Anticancer compound Chinese medicine powder and its preparing method | |
| CN103989714A (en) | Pharmaceutical composition with antitumor effect and preparation of pharmaceutical composition | |
| CN107349383B (en) | Traditional Chinese medicine preparation for treating ovarian cancer and preparation method thereof | |
| CN106138715A (en) | A kind of defying age, the compound preparation and preparation method thereof of resisting fatigue | |
| CN106421154A (en) | Traditional Chinese medicine composition and traditional Chinese medicine preparation containing Chinese eaglewood wood and having cell repairing, anti-aging and anti-canter functions as well as preparation method of traditional Chinese medicine composition | |
| CN105998448A (en) | Method for preparing mulberry oral solution for improving immunity and oral solution prepared by same | |
| CN106109916A (en) | A kind of Fructus Rosae Laevigatae health care oral liquid of slow down aging and preparation method thereof | |
| CN109674831A (en) | A kind of Chinese medicine composition for treating prostate cancer and preparation method thereof and drug |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20121010 |